Pfizer Inc. vs United Airlines Holdings, Inc.: Strategic Comparison
Key Differences at a Glance
| Field | Pfizer Inc. | United Airlines Holdings, Inc. |
|---|---|---|
| Revenue | $62.6B | $59.1B |
| Founded | 1849 | 1926 |
| Employees | 75,000 | 113,200 |
| Market Cap | $148.0B | $38.2B |
| Headquarters | United States | United States |
Quick Stats Comparison
| Metric | Pfizer Inc. | United Airlines Holdings, Inc. |
|---|---|---|
| Revenue | $62.6B | $59.1B |
| Founded | 1849 | 1926 |
| Headquarters | New York, New York | Chicago, Illinois |
| Market Cap | $148.0B | $38.2B |
| Employees | 75,000 | 113,200 |
Pfizer Inc. Revenue vs United Airlines Holdings, Inc. Revenue — Year by Year
| Year | Pfizer Inc. | United Airlines Holdings, Inc. | Leader |
|---|---|---|---|
| 2025 | $62.6B | $59.1B | Pfizer Inc. |
| 2024 | $63.6B | $57.1B | Pfizer Inc. |
| 2023 | $59.6B | $53.7B | Pfizer Inc. |
| 2022 | $101.2B | N/A | Pfizer Inc. |
| 2021 | $81.3B | N/A | Pfizer Inc. |
Business Model Breakdown
Overview: Pfizer Inc. vs United Airlines Holdings, Inc.
This in-depth comparison examines Pfizer Inc. and United Airlines Holdings, Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Pfizer Inc. on its own, evaluating United Airlines Holdings, Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Pfizer Inc. and United Airlines Holdings, Inc. is widest.
On the headline numbers, Pfizer Inc. reports annual revenue of $62.6B against $59.1B for United Airlines Holdings, Inc., while their respective market capitalizations stand at $148.0B and $38.2B. Pfizer Inc. is headquartered in United States and United Airlines Holdings, Inc. operates from United States, and those different home markets shape how each company competes.
Pfizer Inc.: Pfizer has repeatedly reinvented itself around new therapeutic waves, from industrial fermentation and penicillin to Lipitor, vaccines, COVID products, and now oncology. The 2025 profile is not a pandemic windfall story; it is a large pharmaceutical company trying to rebuild a durable growth base.
United Airlines Holdings, Inc.: A network airline is a coordination machine. United's value comes from putting the right aircraft, crew, schedules, airport slots, loyalty incentives, and corporate contracts together so thousands of connecting markets become sellable every day.
Business Models: How Pfizer Inc. and United Airlines Holdings, Inc. Make Money
Pfizer Inc. and United Airlines Holdings, Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Pfizer Inc. and United Airlines Holdings, Inc..
Pfizer Inc. business model: Pfizer makes money from patented prescription medicines, vaccines, oncology products, hospital therapies, rare disease products, collaborations, and global commercial distribution. Its economics depend on R&D success, regulatory approvals, patent protection, reimbursement, and lifecycle management.
United Airlines Holdings, Inc. business model: United makes money from passenger tickets, premium cabins, basic economy, cargo, MileagePlus loyalty economics, co-branded credit card revenue, baggage and seat fees, United Club memberships, and partner revenue. Hubs create network density that lets the airline fill aircraft and price global itineraries.
Competitive Advantage: Pfizer Inc. vs United Airlines Holdings, Inc.
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Pfizer Inc. stack up against those of United Airlines Holdings, Inc..
Pfizer Inc. competitive advantage: Pfizer advantage is scale: global regulatory expertise, manufacturing capacity, clinical development experience, commercial infrastructure, vaccine capabilities, and the ability to acquire or partner for scientific platforms.
United Airlines Holdings, Inc. competitive advantage: United's advantage is its hub network, international route breadth, Star Alliance connectivity, premium-cabin expansion, MileagePlus loyalty base, corporate account strength, and major positions at airports such as Chicago O'Hare, Newark, Denver, Houston, San Francisco, Washington Dulles, and Los Angeles.
Growth Strategy: Where Pfizer Inc. and United Airlines Holdings, Inc. Are Headed
Future prospects matter as much as current results. The growth strategies below explain how Pfizer Inc. and United Airlines Holdings, Inc. each plan to expand from here.
Pfizer Inc. growth strategy: Pfizer growth strategy emphasizes oncology, vaccines, internal medicine, obesity and metabolic research, business development discipline, cost reduction, and global commercial execution. Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
United Airlines Holdings, Inc. growth strategy: United is investing in premium seating, larger aircraft, international routes, operational reliability, MileagePlus, airport clubs, digital service, Starlink connectivity, and network depth at core hubs.
Financial Picture: Pfizer Inc. vs United Airlines Holdings, Inc.
A closer look at the financial trajectory of Pfizer Inc. and United Airlines Holdings, Inc. rounds out the comparison.
Pfizer Inc.: Pfizer reported $62.579 billion of FY2025 revenue, compared with $63.627 billion in FY2024 and $59.553 billion in FY2023. Net income was $7.771 billion in FY2025. Pfizer employed approximately 75,000 people worldwide as of December 31, 2025.
United Airlines Holdings, Inc.: United's 2025 total operating revenue was USD 59.1 billion, up 3.5%. Operating income was USD 4.7 billion. Passenger revenue rose 3.1% as passengers increased 4.3% and capacity increased 6.1%, while other operating revenue grew 10.4% helped by loyalty and club revenue.
Company-Specific SWOT Notes
Pfizer Inc.
Pfizer has manufacturing, regulatory, clinical, and commercial infrastructure that few competitors can match globally.
Major products face loss of exclusivity and pricing pressure, requiring strong replacement revenue.
The Seagen acquisition gives Pfizer a larger oncology platform and ADC pipeline if clinical and commercial execution succeeds.
Medicare negotiation, generic competition, and failed pipeline readouts can compress revenue and margins.
United Airlines Holdings, Inc.
United's advantage is its hub network, international route breadth, Star Alliance connectivity, premium-cabin expansion, MileagePlus loyalty base, corporate account strength, and major positions at airports such as Chicago O'Hare, Newark, Denver, Houston, San Francisco, Washington Dulles, and Los Angeles.
United wins when its hubs, international routes, loyalty program, and premium seats make it the most convenient and valuable airline for high-frequency travelers.
The biggest risk is cost pressure from fuel, labor, aircraft delays, or disruption that outpaces fare and loyalty revenue growth.
United is investing in premium seating, larger aircraft, international routes, operational reliability, MileagePlus, airport clubs, digital service, Starlink connectivity, and network depth at core hubs.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | Pfizer Inc. | Pfizer Inc. reports the larger revenue base ($62.6B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | Pfizer Inc. | Founded in 1849 vs 1926. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | Pfizer Inc. | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | United Airlines Holdings, Inc. | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | Pfizer Inc. | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
Pfizer Inc. reports the larger revenue base ($62.6B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1849 vs 1926. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: Pfizer Inc. or United Airlines Holdings, Inc.?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: Pfizer Inc. vs United Airlines Holdings, Inc.
Is Pfizer Inc. better than United Airlines Holdings, Inc.?
Verdict: Between Pfizer Inc. and United Airlines Holdings, Inc., Pfizer Inc. is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, Pfizer Inc. comes out ahead in this Pfizer Inc. vs United Airlines Holdings, Inc. comparison.
Who earns more — Pfizer Inc. or United Airlines Holdings, Inc.?
Pfizer Inc. earns more with $62.6B in annual revenue versus United Airlines Holdings, Inc.'s $59.1B. Pfizer Inc. leads on total revenue based on latest verified figures.
Which company has higher revenue — Pfizer Inc. or United Airlines Holdings, Inc.?
Pfizer Inc. reported $62.6B, while United Airlines Holdings, Inc. reported $59.1B. The revenue leader is Pfizer Inc. based on latest verified figures.
Pfizer Inc. revenue vs United Airlines Holdings, Inc. revenue — which is higher?
Pfizer Inc. revenue: $62.6B. United Airlines Holdings, Inc. revenue: $59.1B. Pfizer Inc. has the larger revenue base of the two companies.
Sources & References
- SEC EDGAR: Pfizer Inc. Annual Filings (10-K, 8-K)
- Pfizer Inc. Corporate Website
- Pfizer Inc. Annual Report 2025 - Revenue and Financial Data
- sec.gov
- investors.pfizer.com
- pfizer.com
- investors.pfizer.com
- SEC EDGAR: United Airlines Holdings, Inc. Annual Filings (10-K, 8-K)
- United Airlines Holdings, Inc. Corporate Website
- United Airlines Holdings, Inc. Annual Report 2025 - Revenue and Financial Data
- sec.gov
- united.com
- ir.united.com